These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15386717)

  • 21. Effects of cognitive function on functional decline among community-dwelling non-disabled older Japanese.
    Ishizaki T; Yoshida H; Suzuki T; Watanabe S; Niino N; Ihara K; Kim H; Fujiwara Y; Shinkai S; Imanaka Y
    Arch Gerontol Geriatr; 2006; 42(1):47-58. PubMed ID: 16081171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary cortisol excretion as a predictor of incident cognitive impairment.
    Karlamangla AS; Singer BH; Chodosh J; McEwen BS; Seeman TE
    Neurobiol Aging; 2005 Dec; 26 Suppl 1():80-4. PubMed ID: 16280187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depressive symptoms and incident cognitive impairment in cognitively well-functioning older men and women.
    Ng TP; Niti M; Zaw MH; Kua EH
    J Am Geriatr Soc; 2009 Jun; 57(6):1058-63. PubMed ID: 19467145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals.
    Koga H; Takashima Y; Murakawa R; Uchino A; Yuzuriha T; Yao H
    J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):32-7. PubMed ID: 19110142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vision impairment and combined vision and hearing impairment predict cognitive and functional decline in older women.
    Lin MY; Gutierrez PR; Stone KL; Yaffe K; Ensrud KE; Fink HA; Sarkisian CA; Coleman AL; Mangione CM;
    J Am Geriatr Soc; 2004 Dec; 52(12):1996-2002. PubMed ID: 15571533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of mortality in elderly patients with hip fractures: a two-year prospective study of 1,944 patients.
    Söderqvist A; Ekström W; Ponzer S; Pettersson H; Cederholm T; Dalén N; Hedström M; Tidermark J;
    Gerontology; 2009; 55(5):496-504. PubMed ID: 19628932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neuroprotective effects of caffeine: a prospective population study (the Three City Study).
    Ritchie K; Carrière I; de Mendonca A; Portet F; Dartigues JF; Rouaud O; Barberger-Gateau P; Ancelin ML
    Neurology; 2007 Aug; 69(6):536-45. PubMed ID: 17679672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study.
    Gallacher J; Bayer A; Fish M; Pickering J; Pedro S; Dunstan F; Ebrahim S; Ben-Shlomo Y
    Psychosom Med; 2009 Jul; 71(6):659-66. PubMed ID: 19553290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cross-sectional and longitudinal study of the relationship between walking speed and cognitive function in community-dwelling elderly people.
    Soumaré A; Tavernier B; Alpérovitch A; Tzourio C; Elbaz A
    J Gerontol A Biol Sci Med Sci; 2009 Oct; 64(10):1058-65. PubMed ID: 19561146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons.
    Morris MC; Evans DA; Bienias JL; Tangney CC; Hebert LE; Scherr PA; Schneider JA
    Arch Neurol; 2005 Apr; 62(4):641-5. PubMed ID: 15824266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of combined cognitive and physical decline.
    Atkinson HH; Cesari M; Kritchevsky SB; Penninx BW; Fried LP; Guralnik JM; Williamson JD
    J Am Geriatr Soc; 2005 Jul; 53(7):1197-202. PubMed ID: 16108938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-morbid and socio-demographic factors associated with cognitive performance in an elderly community dwelling Irish population.
    Chin AV; O'Connell H; Kirby M; Denihan A; Bruce I; Walsh JB; Coakley D; Lawlor BA; Cunningham C
    Int J Geriatr Psychiatry; 2006 Dec; 21(12):1150-5. PubMed ID: 16955434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
    Knopman DS; Mosley TH; Catellier DJ; Coker LH;
    Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study.
    Avila-Funes JA; Amieva H; Barberger-Gateau P; Le Goff M; Raoux N; Ritchie K; Carrière I; Tavernier B; Tzourio C; Gutiérrez-Robledo LM; Dartigues JF
    J Am Geriatr Soc; 2009 Mar; 57(3):453-61. PubMed ID: 19245415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk and predictors of motor-performance decline in a normally functioning population-based sample of elderly subjects: the Italian Longitudinal Study on Aging.
    Inzitari M; Carlo A; Baldereschi M; Pracucci G; Maggi S; Gandolfo C; Bonaiuto S; Farchi G; Scafato E; Carbonin P; Inzitari D;
    J Am Geriatr Soc; 2006 Feb; 54(2):318-24. PubMed ID: 16460385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does self-rated health predict survival in older persons with cognitive impairment?
    Walker JD; Maxwell CJ; Hogan DB; Ebly EM
    J Am Geriatr Soc; 2004 Nov; 52(11):1895-900. PubMed ID: 15507068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance in cognitive impairment: the InCHIANTI study.
    Geroldi C; Frisoni GB; Paolisso G; Bandinelli S; Lamponi M; Abbatecola AM; Zanetti O; Guralnik JM; Ferrucci L
    Arch Neurol; 2005 Jul; 62(7):1067-72. PubMed ID: 16009759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery Study.
    Rafnsson SB; Deary IJ; Smith FB; Whiteman MC; Fowkes FG
    Psychosom Med; 2007 Jun; 69(5):425-34. PubMed ID: 17556639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study.
    Geda YE; Knopman DS; Mrazek DA; Jicha GA; Smith GE; Negash S; Boeve BF; Ivnik RJ; Petersen RC; Pankratz VS; Rocca WA
    Arch Neurol; 2006 Mar; 63(3):435-40. PubMed ID: 16533972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of cognitive decline through quantitative analysis of the timed up and go test.
    Greene BR; Kenny RA
    IEEE Trans Biomed Eng; 2012 Apr; 59(4):988-95. PubMed ID: 22207634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.